HMGCS2 and posterior cortical atrophy: However, HMGCS2 was not increased in the enzalutamide-resistant PCa cell lines, DuCaP EnzaR and LNCaPabl EnzaR, and also not in CWR22Rv1 (Fig. 3), which have been previously reported as enzalutamide resistant [21].